
The full prescribing information for omalizumab (Xolair) injection has been revised to include a new Boxed Warning and updated Warnings, Precautions, and Adverse Reactions sections to address the risk of anaphylaxis (the onset of action can be delayed for 24 hours or more) when taking this medication [more].